Blossom Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,153
Closed -$384K 72
2025
Q1
$384K Buy
15,153
+2,131
+16% +$55.8K 0.77% 46
2024
Q4
$345K Buy
13,022
+684
+6% +$18.6K 0.66% 45
2024
Q3
$357K Buy
12,338
+305
+3% +$8.9K 0.72% 48
2024
Q2
$337K Buy
12,033
+140
+1% +$3.85K 0.73% 46
2024
Q1
$330K Sell
11,893
-1,095
-8% -$30.4K 0.79% 48
2023
Q4
$374K Buy
12,988
+2,045
+19% +$61.8K 1.01% 39
2023
Q3
$363K Buy
10,943
+1,130
+12% +$40K 1.16% 33
2023
Q2
$360K Buy
9,813
+372
+4% +$14.5K 1.32% 33
2023
Q1
$385K Buy
9,441
+1,084
+13% +$46.8K 1.57% 25
2022
Q4
$428K Buy
8,357
+566
+7% +$27.1K 2.07% 19
2022
Q3
$341K Hold
7,791
1.92% 23
2022
Q2
$408K Buy
7,791
+250
+3% +$12.7K 2.07% 19
2022
Q1
$390K Buy
7,541
+670
+10% +$34.8K 1.76% 23
2021
Q4
$406K Buy
6,871
+1,245
+22% +$61.7K 2% 20
2021
Q3
$242K Buy
+5,626
New +$249K 1.44% 32

Other funds holding PFE

Blossom Wealth Management's PFE Position: Q2 2025 in Review

Blossom Wealth Management sold out of Pfizer (PFE) in Q2 2025, closing a stake of 15,153 shares — an estimated $384K sold.

Blossom Wealth Management first reported a position in PFE in Q3 2021 and held it in 15 quarters. The position peaked at $428K in Q4 2022. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.

  • Blossom Wealth Management reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
  • Blossom Wealth Management sold 15,153 Pfizer shares in Q2 2025, an estimated $384K.
  • Blossom Wealth Management first reported a position in Pfizer in Q3 2021 and held it in 15 quarters.
  • Blossom Wealth Management's Pfizer position peaked at $428K in Q4 2022.
  • 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.

Based on Blossom Wealth Management's 13F filing for Q2 2025, filed 17 Jul 2025.